Venture • Life Science

Aisling Capital Invests In T2 Biosystems

On August 10, 2011, private equity firm Aisling Capital invested in life science company T2 Biosystems

Investment Context
  • This is Aisling Capital’s 18th transaction in the Life Science sector.
  • This is Aisling Capital’s 24th transaction in the United States.
  • This is Aisling Capital’s 2nd transaction in Massachusetts.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date August 10, 2011
Target T2 Biosystems
Sector Life Science
Investor(s) Aisling Capital
Deal Type Venture

Target Company

T2 Biosystems

Lexington, Massachusetts, United States
Rapid, decentralized molecular diagnostic tests and systems that detect fungal and bacterial infections, as well as complementary immunodiagnostics.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Aisling Capital

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 1.8B USD
Size Large
Type Sector Focused
DESCRIPTION

Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.


Deal Context for Investor #
Overall 24 of 56
Sector: Life Science 18 of 42
Type: Venture 17 of 29
State: Massachusetts 2 of 7
Country: United States 24 of 52
Year: 2011 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-01 Miramar Labs

Sunnyvale, California, United States

Miramar Labs is a privately owned medical device company dedicated to launching the next generation energy modality to treat dermatologic medical conditions. Miramar Labs was founded in 2006 and is based in Sunnyvale, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-01 Topaz Pharmaceuticals

Horsham, Pennsylvania, United States

Topaz Pharmaceuticals is a development stage biotechnology company focused on treatments for head lice. Topaz Pharmaceuticals is based in Horsham, Pennsylvania.

Sell -